SEVERAL MONTHS OF IOP REDUCTION WITH 1 IMPLANT1

Discover the DURYSTA® difference:

  • A first-in-class, biodegradable, intracameral implant to reduce IOP in patients with OAG or OHT1
  • 24/7 drug release for several months1,2
  • Delivers drug within the eye to target tissues1,3

SEVERAL MONTHS OF IOP REDUCTION WITH 1 IMPLANT1

  • IOP=intraocular pressure; OAG=open angle glaucoma; OHT=ocular hypertension.
  • Actual DURYSTA® patient.

A first-in-class, biodegradable, intracameral implant for IOP control
24/7 drug delivery for several months1,2

THE IMPLANT THE IMPLANT
THE APPLICATOR THE APPLICATOR

DURYSTA® is directly delivered to target tissues in the anterior chamber angle1,3

Following administration, the intracameral implant is intended to settle within the inferior angle to deliver a sustained release of bimatoprost.1

Bimatoprost is believed to lower IOP in humans by increasing the outflow of aqueous humor through both the trabecular meshwork (conventional) and the uveoscleral routes (unconventional).1

Placement of the implant within the anterior chamber angle allows for close proximity to the tissues involved in both of these outflow pathways, where it delivers bimatoprost 24/7 for several months.1-3

MEET MONICA

A REAL GLAUCOMA PATIENT

After she was diagnosed with glaucoma, Monica started using eye drops to lower her IOP. She had trouble administering them at times and often forgot to use them. Later, her doctor suggested DURYSTA®.

IOP=intraocular pressure.
Actual DURYSTA® patient.

Not actual DURYSTA® patients.

OTHER PATIENTS LIKE MONICA
MAY BE READY FOR DURYSTA®

OTHER PATIENTS LIKE MONICA MAY BE READY FOR DURYSTA®

CONSIDER DURYSTA® FOR YOUR PATIENTS WHO MAY BE:

Not actual DURYSTA® patients.

POTENTIAL PATIENTS MAY SHARE OTHER IMPORTANT CHARACTERISTICS

  • They struggle when administering their drops
  • Open to interventional therapy
  • They lead active lives
  • Often forget their medication

BACK TO MONICA,
AN ACTUAL DURYSTA® PATIENT

SLT=selective laser trabeculoplasty.

MEET MONICA

A REAL GLAUCOMA PATIENT

After she was diagnosed with glaucoma, Monica started using eye drops to lower her IOP. She had trouble administering them at times and often forgot to use them. Later, her doctor suggested DURYSTA®.

IOP=intraocular pressure.
Actual DURYSTA® patient.

OTHER PATIENTS LIKE MONICA MAY BE READY FOR DURYSTA®

CONSIDER DURYSTA® FOR YOUR PATIENTS WHO MAY BE:

Not actual DURYSTA® patients.

POTENTIAL PATIENTS MAY SHARE OTHER IMPORTANT CHARACTERISTICS

  • They struggle when administering their drops
  • Open to interventional therapy
  • They lead active lives
  • Often forget their medication

SLT=selective laser trabeculoplasty.

Efficacy demonstrated in 2 clinical studies
Sustained IOP control, month after month1

ARTEMIS STUDY 1 ARTEMIS STUDY 1
ARTEMIS STUDY 2 ARTEMIS STUDY 2

Consistent Mean IOP Reduction Over Time1

consistent image
image not found

DURYSTA® 10 mcg (N=198)2

image not found

Timolol 0.5% BID (N=198)2

Baseline at Hour 0:
24.6 mmHg

Baseline at Hour 0:
24.6 mmHg

image not foundimage not foundimage not found

Up to 33% mean IOP reduction from baseline1

Consistent Mean IOP Reduction Over Time1

DURYSTA® 10 mcg (N=176)2

Timolol 0.5% BID (N=176)2

Baseline at Hour 0:
24.3 mmHg

Baseline at Hour 0:
24.5 mmHg

Up to 32% mean IOP reduction from baseline1

 

STUDY DESIGN

A safety profile established in 2 clinical studies1

MOST COMMON ADVERSE REACTIONS

Ocular

The most common ocular adverse reaction was conjunctival hyperemia, which occurred in 27% of patients.1

 

Other common ocular adverse reactions reported in 5-10% of patients were foreign body sensation, eye pain, photophobia, conjunctival hemorrhage, dry eye, eye irritation, IOP increased, corneal endothelial cell loss, vision blurred, and iritis.1

 

Ocular adverse reactions occurring in 1-5% of patients were anterior chamber cell, lacrimation increased, corneal edema, aqueous humor leakage, iris adhesions, ocular discomfort, corneal touch, iris hyperpigmentation, anterior chamber flare, anterior chamber inflammation, and macular edema.1

Nonocular

The most common nonocular adverse event was headache, which was observed in 5% of patients.1

You have options when ordering DURYSTA®

 

FOR ORDERING

You have options when ordering DURYSTA®

 

FOR ORDERING

GO TO ALLERGAN DIRECTTM

Choose to order online with Allergan Direct through the buy-and-bill process—or acquire DURYSTA® through a specialty pharmacy. The videos below provide introductions to each of these options.

ORDERING DURYSTA® ONLINE WITH ALLERGAN DIRECT

Allergan Direct offers a convenient experience with 24/7, on-demand flexibility. This solution allows you to place orders, pay invoices, and more.

 

Before ordering, you'll need to set up an Allergan Direct account by calling:  1‌-8‌33‌-D‌URYSTA (1‌-8‌33‌-3‌87‌-9‌782)

Important

  • Call from 8 am to 8 pm ET
  • Have your practice contact information ready—including billing and shipping addresses—and your state license number
  • In order to run a credit check, we will need your business tax ID, bank name, account number, and contact information

If you already have an account for Allergan Direct, remember:

  • There is a minimum order quantity of 2
  • Orders arrive within 2 business days
  • New accounts receive an initial courtesy credit line of $20,000 while we process your credit application

 

HOW TO ORDER THROUGH A SPECIALTY PHARMACY

  • The benefits verification process will determine if your patient's insurance accommodates specialty pharmacy distribution
  • Allergan EyeCue® will then help coordinate the specialty pharmacy experience
  • The specialty pharmacy contacts the patient to verify information and collect their copay
  • Next, your office receives DURYSTA® from the specialty pharmacy and properly stores it
  • Finally, you administer DURYSTA® to the patient when needed

Reimbursement support with Allergan EyeCue®

 

FOR REIMBURSEMENT HELP

Reimbursement support with Allergan EyeCue®

 

FOR REIMBURSEMENT HELP

 

GO TO ALLERGAN EYECUE ®

 

YOUR COMPLETE RESOURCE FOR DURYSTA® REIMBURSEMENT AND ACCESS

 

For your DURYSTA® patients, through Allergan EyeCue® you can:

  • Initiate a benefit verification
  • Request prior authorization support
  • Gain online access to case/patient management
  • Access information about billing, coding, and reimbursement support
  • Request specialty pharmacy enrollment
  • Request claims assistance and appeals support
  • Enroll in the DURYSTA® Savings Program—eligible commercially-insured patients pay $0* for up to one implant per eye
  • Submit claims for reimbursement under the DURYSTA® Savings Program

Before you can begin taking advantage of this resource for ongoing DURYSTA® support, an Allergan EyeCue® account is required. Details are available at the Allergan EyeCue® site.

*Offer valid only for commercially-insured patients with plans covering DURYSTA®; patient out-of-pocket expense may vary. Offer not valid for patients receiving reimbursement from Medicare, Medicaid, or any other federal, state, or government-funded healthcare program. See Program Terms, Conditions, and Eligibility Criteria here or visit www.durystasavingsprogram.com

The DURYSTA® Physician Training Portal

 

FOR ADMINISTRATION HELP

 

VISIT THE TRAINING PORTAL

 

DESIGNED TO INTRODUCE YOU TO THE IMPLANT DELIVERY DIRECTIONS FOR DURYSTA®

 

The Physician Training Portal provides:

  • An overview of the drug delivery system and mechanism of action
  • A video series featuring Paul Singh, MD, with insights on patient selection, patient discussion, and administration
  • Demonstrations of correct administration technique
  • Examples of typical implant behavior following administration
  • A guide through various troubleshooting scenarios
  • Downloadable resources and supplements from Cataract & Refractive Surgery Today

Physician Administration Guide

A complete reference for the DURYSTA® administration procedure

DOWNLOAD

Download materials and resources for your practice and your patients

 

For Your Practice

 

ORDERING

 

How to Order Flashcard

A handy reference to consult when ordering DURYSTA®

DOWNLOAD

REIMBURSEMENT

 

Patient Enrollment Form

Quickly enroll patients in Allergan EyeCue ® to begin taking advantage of the available resources

DOWNLOAD

                             

 

Billing and Coding Guide

A brief overview of billing and coding information for DURYSTA®

DOWNLOAD

ADDITIONAL RESOURCES

 

 

Buy-and-Bill/Specialty Pharmacy Flashcard

Allergan EyeCue® Overview

DURYSTA® Savings Program Reimbursement Request Form

DURYSTA® Procedure Consent Form

Sample CMS-1500 Form
Sample UB-04 Form

For Your Patients

DURYSTA® In-Office Patient Screener

A tool to help identify patients who might be potential candidates for DURYSTA®

DOWNLOAD
DURYSTA® Savings Program Patient Flashcard

All the information eligible patients need to enroll and begin saving on their DURYSTA® prescription costs

DOWNLOAD
TOP